The Hill

FDA approves higher dose of Wegovy

The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg.
CNBC

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

The Food and Drug Administration approved a higher dose version of Novo Nordisk's blockbuster weight loss injection Wegovy, as the company pushes to win back market share from Eli Lilly. The high-dose ...
Reuters

US FDA approves higher dose of Novo's Wegovy under new fast-track review program

March 19 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Thursday the U.S. Food and Drug Administration has approved a higher dose of its blockbuster weight-loss drug Wegovy. The ...
Labroots

New Antibiotic Stops C. Difficile, Protects Microbiome

An experimental antibiotic called EVG7 has shown promise against gram-positive bacterium Clostridioides difficile, the leading cause of healthcare and antibiotic-associated diarrhea in the US and ...
New York Post

I swapped my coffee for Dose Liver Shots: Here’s the truth about the trendy supplement

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Earlier this year, my wife and I welcomed our son ...
Oregonian

Dear Doctor: Is uncommon C. diff causing this patient’s chronic diarrhea?

DEAR DR. ROACH: I am a 76-year-old male who is in relatively good health. For the past six months, I have been experiencing diarrhea on and off. I initially spoke to my general physician, and he ...
C&EN

Quinoline tag helps vancomycin breach gram-negative defenses

Vancomycin is a common antibiotic used to treat gram-positive bacterial infections. It targets a key building block of the bacterial cell wall called Lipid II, but it can’t reach this lipid in ...
Medscape

Fecal Transplant Benefits in Primary C Difficile Infection Similar to Vancomycin

Fecal microbiota transplantation (FMT), shown to be effective in the treatment of recurrent Clostridioides difficile infection (CDI), also shows significant benefit in the treatment of primary CDI, ...
The New England Journal of Medicine

Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...
Healio

Prophylactic vancomycin may reduce risk for recurrent C. difficile

Please provide your email address to receive an email when new articles are posted on . However, this finding did not reach statistical significance, the researchers noted. “This is the first ...
Monthly Prescribing Reference

Tyzavan, a Ready-to-Infuse Vancomycin Formulation, Gets FDA Approval

Tyzavan can be stored at room temperature and has a shelf life of 16 months. The Food and Drug Administration (FDA) has approved Tyzavan ™ (vancomycin injection, USP), a novel ready-to-infuse, room ...